Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3109361000168119 | Tripacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 10 microgram + diphtheria toxoid 30 international units + tetanus toxoid 40 international units) injection, 1 x 0.5 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3109371000168113 | Tripacel injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tripacel injection, 0.5 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Tripacel injection, 0.5 mL vial | Is a | Tripacel injection, 0.5 mL vial | true | Inferred relationship | Some | ||
| Tripacel injection, 0.5 mL vial | has TPUU | Tripacel injection, 0.5 mL vial | true | Inferred relationship | Some | 1 | |
| Tripacel injection, 0.5 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Tripacel injection, 0.5 mL vial | has TP | Tripacel | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR